← Evidence map

ReviewFrontiers in immunology2025

Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitis.

Aude G Chapuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41459525